Hipopara-Red, Real Life Experience in 322 Patients With Hypoparathyroidism

Area of Science:

• Endocrinology
• Rare Diseases
• Metabolic Bone Diseases

Background:

• Hypoparathyroidism (HP) is a rare endocrine disorder with unclear natural history and long-term complications.
• Optimal clinical management strategies for HP remain to be fully elucidated.

Purpose of the Study:

• To describe the natural history and clinical characteristics of chronic hypoparathyroidism.
• To identify potential areas for improvement in patient management.

Main Methods:

• Retrospective observational analysis of 322 chronic hypoparathyroidism patients from 7 centers in Buenos Aires, Argentina (1985-2018).
• Data collected included demographics, etiology, clinical complications, biochemical parameters, DXA scans, and treatment details.

Main Results:

• The cohort was predominantly female (85.7%), with a mean age of 55.2 years.
• Surgical etiology (thyroid carcinoma, benign thyroid disease) accounted for 90.7% of cases.
• Neuromuscular symptoms (40.9%), renal insufficiency (22.4%), and hyperphosphatemia (42%) were common complications.

Conclusions:

• Despite expert follow-up, clinical management was heterogeneous and potentially insufficient for managing HP complications.
• Nearly 70% of patients met criteria for considering recombinant human parathyroid hormone (rhPTH) 1-84 therapy.
• Improved awareness and management strategies are crucial for better patient outcomes in hypoparathyroidism.